These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3637148)

  • 1. I.v. medication compatibility chart.
    Gordon EL
    Crit Care Nurse; 1986; 6(4):82-3. PubMed ID: 3637148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incompatibility and other problems in adding drugs to intravenous fluids].
    Hvidberg E; Bols T; Jacobsen N
    Ugeskr Laeger; 1973 Jun; 135(24):1221-9. PubMed ID: 4754570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physicochemical incompatibilities of injectable drugs].
    Hoffman M; Hazebroucq G
    Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation of a compatibility chart for intravenous drug therapy in neonatal and pediatric intensive care units].
    Höpner JH; Schulte A; Thiessen J; Knuf M; Huth RG
    Klin Padiatr; 2007; 219(1):37-43. PubMed ID: 17205430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixing drugs with intravenous infusions.
    Drug Ther Bull; 1970 Jul; 8(14):53-6. PubMed ID: 5451629
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT
    Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug compatibility and incompatibility in infusion solutions].
    Viering HD
    Infusionstherapie (1973); 1973 Oct; 1(1):74. PubMed ID: 4806247
    [No Abstract]   [Full Text] [Related]  

  • 8. The need for chemical compatibility studies of subcutaneous medication combinations used in palliative care.
    Rose M; Currow DC
    J Pain Palliat Care Pharmacother; 2009; 23(3):223-30. PubMed ID: 19670019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility of primary-piggyback solution combinations.
    Arnold TR; Eder J; Lower B
    Am J Hosp Pharm; 1978 Mar; 35(3):249-50. PubMed ID: 626204
    [No Abstract]   [Full Text] [Related]  

  • 10. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
    Allen LV; Levinson RS; Phisutsinthop D
    Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration.
    Kershaw BP; Monnier HL; Mason JH
    Am J Hosp Pharm; 1993 Jul; 50(7):1360, 1362-3. PubMed ID: 8362868
    [No Abstract]   [Full Text] [Related]  

  • 12. IV bolus: effective, but potentially hazardous (continuing education credit).
    Burman R; Berkowitz HS
    Crit Care Nurse; 1986; 6(1):22-8. PubMed ID: 3633789
    [No Abstract]   [Full Text] [Related]  

  • 13. Incompatibilities of additives to intravenous infusion fluids.
    Bourne D
    Aust Nurses J; 1976 Dec-1977 Jan; 6(6-7):23, 35. PubMed ID: 1053312
    [No Abstract]   [Full Text] [Related]  

  • 14. Blocking i.v. drug incompatibilities.
    Trissel LA
    Nursing; 1993 Jun; 23(6):74. PubMed ID: 8510845
    [No Abstract]   [Full Text] [Related]  

  • 15. A guide to admixture compatibility. Part 3.
    RN; 1973 Dec; 36(12):32-7. PubMed ID: 4490643
    [No Abstract]   [Full Text] [Related]  

  • 16. I.V. additives move to the pharmacy.
    Peritore SP; Rosenberg JM
    Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of a drug additives programme.
    Elliott B
    Med J Aust; 1975 Jan; 1(1):17-8. PubMed ID: 805347
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physicochemical incompatibility of injectable drugs: practical considerations].
    Grenet I; Hazebroucq G
    Therapie; 1995; 50(3):191-5. PubMed ID: 7667797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bretylium tosylate intravenous admixture compatibility. II: Dopamine, lidocaine, procainamide, and nitroglycerin.
    Lee YC; Malick AW; Amann AH; Baaske DM; Shah JJ; Wagenknecht DM; Carter JE
    Am J Hosp Pharm; 1981 Feb; 38(2):183-7. PubMed ID: 6782870
    [No Abstract]   [Full Text] [Related]  

  • 20. Compatibility of glycopyrrolate injection with commonly used infusion solutions and additives.
    Ingallinera TS; Kapadia AJ; Hagman D; Klioze O
    Am J Hosp Pharm; 1979 Apr; 36(4):508-10. PubMed ID: 433937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.